Literature DB >> 25613482

HER-2-induced PI3K signaling pathway was involved in the pathogenesis of gastric cancer.

Y F Fu1, R Gui1, J Liu1.   

Abstract

Human epidermal growth factor receptor-2 (HER-2) overexpression was closely associated with the tumor growth and invasion, we here aimed to investigate the mechanism of HER-2 mediation in the pathogenesis of gastric cancer (GC). We first detected the expression of HER-2 in GC cell line SGC-7901 and then examined the levels of nuclear factor-κB (NF-κB), matrix metalloproteinase-9 (MMP-9) and intercellular adhesion molecule-1 (ICAM-1) and the association between them by molecular methods. Statistical analysis was used to compare the significance. We further detected the possible molecular mechanism involved in their relationship in the SGC-7901 genesis. The MMP-9, NF-κB and secretory type (s-ICAM-1) levels were significantly greater in peripheral blood serum from SGC-7901 than healthy control GES-1 (P<0.01). ICAM-1, MMP-9 and NF-κB mRNA and protein levels were more highly expressed in SGC-7901 than healthy control GES-1. The expression levels of NF-κB, MMP-9 and ICAM-1 were positively related in GC cell line SGC-7901, which was HER-2 positive. The HER-2 positive SGC-7901 secreted more transforming growth factor beta 1 (TGF-β1) and resultantly activated MMP-9 to enhance s-ICAM-1 secretion and further studies showed that phosphatidylinositol-3 kinase (PI3K)/Akt/NF-κB signaling pathway was involved in GC pathogenesis. The GC cells that express the HER-2 oncogene spur the activation of NF-κB that can upregulate the expression of ICAM-1 and induce the expression of MMP-9, which hydrolyzes ICAM-1 into s-ICAM-1 to promote tumor immune escape. TGF-β1-induced PI3K/Akt/NF-κB signaling pathway was involved in the pathogenesis of GC and they could be a new target for cancer therapy. The GC cells that express the HER-2 oncogene spur the activation of NF-κB that can upregulate the expression of ICAM-1 and induce the expression of MMP-9, which hydrolyzes ICAM-1 into s-ICAM-1 to promote tumor immune escape. TGF-β1-induced PI3K/Akt/NF-κB signaling pathway was involved in the pathogenesis of GC and they could be a new target for cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25613482     DOI: 10.1038/cgt.2014.80

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  37 in total

Review 1.  [The significance of metalloproteinases and their inhibitors in gastric cancer].

Authors:  Marta Lukaszewicz-Zajac; Barbara Mroczko; Maciej Szmitkowski
Journal:  Postepy Hig Med Dosw (Online)       Date:  2009-06-05       Impact factor: 0.270

2.  Association of functional polymorphisms in MMPs genes with gastric cardia adenocarcinoma and esophageal squamous cell carcinoma in high incidence region of North China.

Authors:  Yan Li; Dong-lan Sun; Ya-nan Duan; Xiao-juan Zhang; Na Wang; Rong-miao Zhou; Zhi-feng Chen; Shi-jie Wang
Journal:  Mol Biol Rep       Date:  2009-06-28       Impact factor: 2.316

3.  Impact of Annexin A3 expression in gastric cancer cells.

Authors:  S Y Yu; Y Li; L Q Fan; Q Zhao; B B Tan; Y Liu
Journal:  Neoplasma       Date:  2014       Impact factor: 2.575

4.  Toll-like receptor 2 promotes invasion by SGC-7901 human gastric carcinoma cells and is associated with gastric carcinoma metastasis.

Authors:  Huan Yang; Bo Wang; Jie Yan; Tao Wang; Xiao-Ni Zhou; Hui-Yan Wen; Xue-Ming Zhu
Journal:  Ann Clin Lab Sci       Date:  2014       Impact factor: 1.256

5.  Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.

Authors:  Yasushi Adachi; Rong Li; Hiroyuki Yamamoto; Yongfen Min; Wenhua Piao; Yu Wang; Arisa Imsumran; Hua Li; Yoshiaki Arimura; Choon-Taek Lee; Kohzoh Imai; David P Carbone; Yasuhisa Shinomura
Journal:  Carcinogenesis       Date:  2009-06-03       Impact factor: 4.944

6.  ZNF139 promotes tumor metastasis by increasing migration and invasion in human gastric cancer cells.

Authors:  Y Li; B B Tan; Q Zhao; L Q Fan; D Wang; Y Liu
Journal:  Neoplasma       Date:  2014       Impact factor: 2.575

7.  [The relationship of MMP-9, VEGF and PCNA expressions and their clinical significance in gastric adenocarcinoma].

Authors:  Feng-Juan Zhao; Chun-Sheng Kang; Xiao-Wei Cui; Xiao-Mei Song; Jian Liu; Qing-Yu Zhang
Journal:  Zhonghua Nei Ke Za Zhi       Date:  2009-02

8.  Inhibitory effects of adenovirus mediated Akt1 and PIK3R1 shRNA on the growth of malignant tumor cells in vitro and in vivo.

Authors:  Yanchao Fu; Qingyu Zhang; Chunsheng Kang; Jing Zhang; Kairu Zhang; Peiyu Pu; Guangxiu Wang; Tao Wang
Journal:  Cancer Biol Ther       Date:  2009-06-25       Impact factor: 4.742

9.  Integrin-linked kinase silencing induces a S/G2/M phases cell cycle slowing and modulates metastasis-related genes in SGC7901 human gastric carcinoma cells.

Authors:  Wei Song; Chunming Zhao; Rui Jiang
Journal:  Tumori       Date:  2013 Mar-Apr

10.  Combined features based on MT1-MMP expression, CD11b + immunocytes density and LNR predict clinical outcomes of gastric cancer.

Authors:  Chun-Wei Peng; Lin-Wei Wang; Min Fang; Gui-Fang Yang; Yan Li; Dai-Wen Pang
Journal:  J Transl Med       Date:  2013-06-20       Impact factor: 5.531

View more
  6 in total

1.  Global metabolomic profiling of trastuzumab resistant gastric cancer cells reveals major metabolic pathways and metabolic signatures based on UHPLC-Q exactive-MS/MS.

Authors:  Wenhu Liu; Qiang Wang; Jinxia Chang
Journal:  RSC Adv       Date:  2019-12-13       Impact factor: 4.036

2.  Trastuzumab increases pulmonary vein arrhythmogenesis through modulating pulmonary vein electrical and conduction properties via phosphatidylinositol 3-kinase signaling.

Authors:  Jun-Hei Chang; Chen-Chuan Cheng; Yen-Yu Lu; Yao-Chang Chen; Shih-Ann Chen; Yi-Jen Chen
Journal:  Iran J Basic Med Sci       Date:  2020-07       Impact factor: 2.699

3.  Biglycan-mediated upregulation of MHC class I expression in HER-2/neu-transformed cells.

Authors:  Karthikeyan Subbarayan; Sandra Leisz; Claudia Wickenhauser; Daniel Bethmann; Chiara Massa; André Steven; Barbara Seliger
Journal:  Oncoimmunology       Date:  2018-01-16       Impact factor: 8.110

Review 4.  Targeting the Oncogenic FGF-FGFR Axis in Gastric Carcinogenesis.

Authors:  Jinglin Zhang; Patrick M K Tang; Yuhang Zhou; Alfred S L Cheng; Jun Yu; Wei Kang; Ka Fai To
Journal:  Cells       Date:  2019-06-25       Impact factor: 6.600

Review 5.  Progranulin Regulates Inflammation and Tumor.

Authors:  Chunxiao Liu; Jiayi Li; Wenjing Shi; Liujia Zhang; Shuang Liu; Yingcong Lian; Shujuan Liang; Hongyan Wang
Journal:  Antiinflamm Antiallergy Agents Med Chem       Date:  2020

6.  The Msi1-mTOR pathway drives the pathogenesis of mammary and extramammary Paget's disease.

Authors:  Yongli Song; Christian F Guerrero-Juarez; Zhongjian Chen; Yichen Tang; Xianghui Ma; Cong Lv; Xueyun Bi; Min Deng; Lina Bu; Yuhua Tian; Ruiqi Liu; Ran Zhao; Jiuzhi Xu; Xiaole Sheng; Sujuan Du; Yeqiang Liu; Yunlu Zhu; Shi-Jun Shan; Hong-Duo Chen; Yiqiang Zhao; Guangbiao Zhou; Jianwei Shuai; Fazheng Ren; Lixiang Xue; Zhaoxia Ying; Xing Dai; Christopher J Lengner; Bogi Andersen; Maksim V Plikus; Qing Nie; Zhengquan Yu
Journal:  Cell Res       Date:  2020-05-26       Impact factor: 46.297

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.